
Columbus Venture Partners invests in life‑science companies, focusing on biotechnology therapies and industrial biotech infrastructure that address rare, difficult‑to‑treat diseases. They target high‑growth, early‑stage ventures where they can help build end‑to‑end value chains from discovery to manufacturing, aiming for strong returns while advancing healthcare globally.
Industries
Industry breakdown
Top industries in the portfolio
Geography
Geographic scope
Global
Geography breakdown
Darker regions = more portfolio companies
Top 5 countries
United States of America
41.2%United Kingdom
17.6%Venezuela
5.9%Singapore
5.9%Brazil
5.9%Other
11.8%Countries with a higher share of the portfolio are shaded darker on the map.
Stages
Stage indicator
Seed → Series C+
Stage breakdown
Portfolio by stage
Portfolio vintage
Companies by founded year
Fund details
Funds
Life Science I
Vintage 2016 • $46.2M
Life Science II
Vintage 2019 • $81.4M
Life Sciences III
Vintage 2021 • $132M
Life Sciences IV
Vintage 2023 • $165M
Healthcare Growth Innvierte I
Vintage 2024 • $110M
Fund IV
Vintage 2024 • $165M
Check sizes
Min: $16.5M
Typical: $106.2M
Max: $165M